InterTabac 2025 Highlights Europe’s Vaping Dilemma: Tighter Regulation, Constrained Innovation

Sep.19.2025
InterTabac 2025 Highlights Europe’s Vaping Dilemma: Tighter Regulation, Constrained Innovation
According to 2Firsts’ on-site observations, the vaping halls at InterTabac 2025 have visibly cooled: fewer exhibitors, a weaker presence from major brands, and scarce stage activations; new product momentum is weak and homogenization has intensified. Tightening regulation and policy uncertainty are squeezing innovation, pushing companies to replicate proven models—overall, a “cautious showcase.”

InterTabac 2025 is underway in Dortmund, Germany. 2Firsts’ on-site reporting finds that this year’s vaping halls feel noticeably different from last year.

 

First, in terms of exhibitors, the number of vaping brands has fallen, and the presence of major players is less pronounced than in 2024. Overall foot traffic is similar, but exhibitors’ enthusiasm is clearly lower. From booth size to finishing details, the change is palpable. Last year many stands featured dancers, DJs, and other performances; such spectacles are rarely seen this year.

 

Second, at the product level, genuinely new launches are scarce. Homogenization is striking: booths are dominated by pod-based and open-system devices with little real novelty. Many products use transparent tanks and “2+10” or “0+10” bundle formats, but differences among offerings are limited.

 

Conversations with multiple exhibitors suggest that, beyond a general slowdown in European innovation, regulatory pressure is a key driver. Germany’s rules are stringent; during the show, plainclothes customs officers were reportedly checking on site whether products carried tax stamps. A tax stamp implies compliance with the TPD (EU Tobacco Products Directive), which tightly restricts product formats and specifications—leaving manufacturers little room to design and innovate.

 

In fact, Europe’s broader novel-nicotine market is in a period of regulatory uncertainty. Without clear policy signals, companies are reluctant to commit to R&D and instead prefer to “replicate” existing winners.

 

Overall, this year’s Dortmund show feels more like a “cautious showcase.” Under regulatory pressure and market uncertainty, the industry’s appetite for innovation has clearly weakened.

 


For more on-the-ground coverage, visit the 2Firsts InterTabac Special Section.

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

 Zyn Emerges as MAGA Cultural Symbol Amid FDA Policy Shift
Zyn Emerges as MAGA Cultural Symbol Amid FDA Policy Shift
According to The Wall Street Journal, nicotine pouch brand Zyn has rapidly gained popularity across the Trump administration and conservative political circles, including among U.S. Health Secretary Robert F. Kennedy Jr.
Business
May.20
Belgian Health Minister Calls Tobacco Industry “Criminal” After Court Undermines Supermarket Sales Ban
Belgian Health Minister Calls Tobacco Industry “Criminal” After Court Undermines Supermarket Sales Ban
Belgian Health Minister Frank Vandenbroucke described the tobacco industry as a “criminal” sector with “no future” during an appearance on VRT’s current affairs program Ter Zake. His comments came after Belgium’s Constitutional Court ruled that a government ban on cigarette and vape sales in supermarkets was discriminatory because it allowed small shops to sell tobacco products while prohibiting larger retailers from doing so.
May.07 by 2FIRSTS.ai
Australia Quantifies Black Market for First Time, Illicit Nicotine Products Account for About 80% of Consumption
Australia Quantifies Black Market for First Time, Illicit Nicotine Products Account for About 80% of Consumption
The Australian Bureau of Statistics (ABS) has released its first estimate of the illicit nicotine market, finding that about 80% of cigarettes, vapes and other nicotine products consumed in 2025 came from illegal sources, reigniting debate over tobacco taxation and enforcement policies.
Jun.03
BAT Restructuring to Affect 9,000 Roles as Tobacco Group Pushes Cost Cuts and AI
BAT Restructuring to Affect 9,000 Roles as Tobacco Group Pushes Cost Cuts and AI
British American Tobacco (BAT) plans to cut about 5,500 jobs globally and shift around 3,500 roles to strategic partners by the end of 2026, affecting about 9,000 roles in total, as the company seeks to simplify operations, strengthen technology capabilities and deliver £600 million in annual savings by 2028.
BAT
Jun.29
How AI Is Rewriting the Talent Playbook for the Nicotine Industry: JTI’s Case
How AI Is Rewriting the Talent Playbook for the Nicotine Industry: JTI’s Case
AI is moving from a back-office tool to a core organizational capability in the nicotine industry. Based on JTI’s responses, this 2Firsts feature examines how AI is reshaping talent strategy, internal mobility, decision-making and human accountability as global tobacco companies compete in the shift toward new nicotine categories.
Jun.17
FDA Tobacco Center Plans Faster Review Process for Certain Supplemental PMTAs
FDA Tobacco Center Plans Faster Review Process for Certain Supplemental PMTAs
FDA Center for Tobacco Products Acting Director Bret Koplow issued a statement on May 7 outlining new steps to accelerate tobacco product premarket application review. The statement said CTP reduced the backlog of applications by approximately 70% in 2025 and that there is no longer a queue for PMTAs pending acceptance review.
May.09 by 2FIRSTS.ai